CXCR2 and rhabdomyosarcoma: Therefore, we evaluated the activity of a dual CAR construct, expressing both B7-H3 CAR and human CXCR2 (Fig. 5A), that had previously demonstrated superior activity in a rhabdomyosarcoma model [44].